Essential Manual of 24 Hour Blood Pressure Management: From Morning to Nocturnal Hypertension

Essential Manual of 24 Hour Blood Pressure Management: From Morning to Nocturnal Hypertension

Volumn , Issue , 2015, Pages 1-138

  Kario, Kazuomi ^a,b  

^a JICHI MEDICAL UNIVERSITY   (Japan)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85186839121     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Book

References (182)

1. Kario K, Pickering TG, Umeda Y, Hoshide S, Hoshide Y, Morinari M, Murata M, Kuroda T, Schwartz JE, Shimada K. Morning surge in blood pressure as a predictor of silent and clinical cerebrovascular disease in elderly hypertensives: a prospective study. Circulation. 2003;107:1401-1406.
2. Kario K, Ishikawa J, Pickering TG, Hoshide S, Eguchi K, Morinari M, Hoshide Y, Kuroda T, Shimada K. Morning hypertension: the strongest independent risk factor for stroke in elderly hypertensive patients. Hypertens Res. 2006;29:581-587.
3. Kario K. Clinician’s Manual on Early Morning Risk Management in Hypertension. Science Press, London, UK, pp. 1-68, 2004.
4. Kario K. Orthostatic hypertension-a new haemodynamic cardiovascular risk factor. Nat Rev Nephrol. 2013;9:726-738.
5. Kario K. Proposal of a new strategy for ambulatory blood pressure profi le-based management of resistant hypertension in the era of renal denervation. Hypertens Res. 2013;36:478-484.
6. Kario K, Kuwabara M, Hoshide S, Nagai M, Shimpo M. Effects of nighttime single-dose administration of vasodilating vs sympatholytic antihypertensive agents on sleep blood pressure in hypertensive patients with sleep apnea syndrome. J Clin Hypertens (Greenwich). 2014;16(6):459-466.
7. Kario K, Saito I, Kushiro T, Teramukai S, Ishikawa Y, Mori Y, Kobayashi F, Shimada K. Home blood pressure and cardiovascular outcomes in patients during antihypertensive therapy: primary results of HONEST, a large-scale prospective, real-world observational study. Hypertension. 2014;64:989-996.
8. Kario K. Proposal of a new strategy for ambulatory blood pressure profi le-based management of resistant hypertension in the era of renal denervation. Hypertens Res. 2013;36:478-484.
9. Kario K. Clinician’s Manual on Early Morning Risk Management in Hypertension. Science Press, London, UK, pp. 1-68, 2004.
10. Muller JE, Tofler GH, Stone PH. Circadian variation and triggers of onset of acute cardiovascular disease. Circulation. 1989;79:733-743.
11. Kario K, Pickering TG, Umeda Y, Hoshide S, Hoshide Y, Morinari M, Murata M, Kuroda T, Schwartz JE, Shimada K. Morning surge in blood pressure as a predictor of silent and clinical cerebrovascular disease in elderly hypertensives: a prospective study. Circulation. 2003;107:1401-1406.
12. Kario K. Time for focus on morning hypertension. Pitfall of current antihypertensive medication. Am J Hypertens. 2005;18:149-151.
13. Kario K, Ishikawa J, Pickering TG, Hoshide S, Eguchi K, Morinari M, Hoshide Y, Kuroda T, Shimada K. Morning hypertension: the strongest independent risk factor for stroke in elderly hypertensive patients. Hypertens Res. 2006;29:581-587.
14. Li Y, Thijs L, Hansen TW, Kikuya M, Boggia J, Richart T, Metoki H, Ohkubo T, Torp- Pedersen C, Kuznetsova T, Stolarz-Skrzypek K, Tikhonoff V, Malyutina S, Casiglia E, Nikitin Y, Sandoya E, Kawecka-Jaszcz K, Ibsen H, Imai Y, Wang J, Staessen JA; International Database on Ambulatory Blood Pressure Monitoring in Relation to Cardiovascular Outcomes Investigators. Prognostic value of the morning blood pressure surge in 5645 subjects from 8 populations. Hypertension. 2010;55:1040-1048.
15. Kario K. Morning surge in blood pressure and cardiovascular risk: evidence and perspectives. Hypertension. 2010;56:765-773.
16. Nishinaga M, Takata J, Okumiya K, Matsubayashi K, Ozawa T, Doi Y. High morning home blood pressure is associated with a loss of functional independence in the community- dwelling elderly aged 75 years or older. Hypertens Res. 2005;28(8):657-663.
17. Asayama K, Ohkubo T, Kikuya M, Obara T, Metoki H, Inoue R, Hara A, Hirose T, Hoshi H, Hashimoto J, Totsune K, Satoh H, Imai Y. Prediction of stroke by home “morning” versus “evening” blood pressure values: the Ohasama study. Hypertension. 2006;48(4):737-743.
18. Kario K, Saito I, Kushiro T, Teramukai S, Ishikawa Y, Mori Y, Kobayashi F, Shimada K. Home blood pressure and cardiovascular outcomes in patients during antihypertensive therapy: primary results of HONEST, a large-scale prospective, real-world observational study. Hypertension. 2014;64(5):989-996.
19. Kario K. Morning surge in blood pressure in hypertension: clinical relevance, prognostic signifi cance and therapeutic approach. In: Special Issues in Hypertension (AE Berbari, G Mancia, eds). Springer Inc ., pp. 71-89, 2012.
20. Shimamoto K, Ando K, Fujita T, Hasebe N, Higaki J, Horiuchi M, Imai Y, Imaizumi T, Ishimitsu T, Ito M, Ito S, Itoh H, Iwao H, Kai H, Kario K, Kashihara N, Kawano Y, Kim-Mitsuyama S, Kimura G, Kohara K, Komuro I, Kumagai H, Matsuura H, Miura K, Morishita R, Naruse M, Node K, Ohya Y, Rakugi H, Saito I, Saitoh S, Shimada K, Shimosawa T, Suzuki H, Tamura K, Tanahashi N, Tsuchihashi T, Uchiyama M, Ueda S, Umemura S. The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2014). Hypertens Res. 2014;37:253-387.
21. Mancia G, Fagard R, Narkiewicz K, Redón J, Zanchetti A, Böhm M, Christiaens T, Cifkova R, De Backer G, Dominiczak A, Galderisi M, Grobbee DE, Jaarsma T, Kirchhof P, Kjeldsen SE, Laurent S, Manolis AJ, Nilsson PM, Ruilope LM, Schmieder RE, Sirnes PA, Sleight P, Viigimaa M, Waeber B, Zannad F; Task Force Members. 2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2013;31:1281-1357.
22. McManus RJ, Caulfi eld M, Williams B; National Institute for Health and Clinical Excellence. NICE hypertension guideline 2011: evidence based evolution. BMJ. 2012; 344: e181.
23. Pickering TG, Eguchi K, Kario K. Masked hypertension: a review. Hypertens Res. 2007;30(6):479-488.
24. Matsui Y, Eguchi K, Shibasaki S, Shimizu M, Ishikawa J, Shimada K, Kario K. Association between the morning-evening difference in home blood pressure and cardiac damage in untreated hypertensive patients. J Hypertens. 2009;27:712-720.
25. Matsui Y, Eguchi K, Shibasaki S, Ishikawa J, Shimada K, Kario K. Morning hypertension assessed by home monitoring is a strong predictor of concentric left ventricular hypertrophy in patients with untreated hypertension. J Clin Hypertens. 2010;12:776-783.
26. Shibuya Y, Ikeda T, Gomi T. Morning rise of blood pressure assessed by home blood pressure monitoring is associated with left ventricular hypertrophy in hypertensive patients receiving long-term antihypertensive medication. Hypertens Res. 2007;30:903-911.
27. Johansson JK, Niiranen TJ, Puukka PJ, Jula AM. Prognostic value of the variability in home-measured blood pressure and heart rate: the Finn-Home Study. Hypertension. 2012;59(2):212-218.
28. Kario K. Preceding linkage between a morning surge in blood pressure and small artery remodeling: an indicator of prehypertension? J Hypertens. 2007;25:1573-1575.
29. Eguchi K, Matsui Y, Shibasaki S, Hoshide S, Kabutoya T, Ishikawa J, Ishikawa S, Shimada K, Kario K; Japan Morning Surge-1 (JMS-1) Study Group. Controlling evening BP as well as morning BP is important in hypertensive patients with prediabetes/diabetes:the JMS-1 study. Am J Hypertens. 2010;23:522-527.
30. Kario K, Shimada K, Schwartz JE, Matsuo T, Hoshide S, Pickering TG. Silent and clinically overt stroke in older Japanese subjects with white-coat and sustained hypertension. J Am Coll Cardiol. 2001;38:238-245.
31. Kario K, Matsuo T, Kobayashi H, Imiya M, Matsuo M, Shimada K. Nocturnal fall of blood pressure and silent cerebrovascular damage in elderly hypertensive patients: advanced silent cerebrovascular damage in extreme dippers. Hypertension. 1996;27:130-135.
32. Kario K, Pickering TG, Matsuo T, Hoshide S, Schwartz JE, Shimada K. Stroke prognosis and abnormal nocturnal blood pressure falls in older hypertensives. Hypertension. 2001;38:852-857.
33. Kario K, Eguchi K, Umeda Y, Hoshide S, Hoshide Y, Morinari M, Murata M, Kuroda T, Shimada K, Pickering TG, Schwartz JE. Morning surge in blood pressure as a predictor of silent and clinical cerebrovascular disease in elderly hypertensives: response. Circulation. 2003;108:e72-e73.
34. Hoshide S, Kario K, Yano Y, Haimoto H, Yamagiwa K, Uchiba K, Nagasaka S, Matsui Y, Nakamura A, Fukutomi M, Eguchi K, Ishikawa J; J-HOP study group. Association of morning and evening blood pressure at home with asymptomatic organ damage in the J-HOP Study. Am J Hypertens. 2014;27(7):939-947.
35. Kario K. Morning surge in blood pressure: a phenotype of systemic hemodynamic atherothrombotic syndrome. Am J Hypertens. 2015;28(1):7-9.
36. Bombelli M, Fodri D, Toso E, Macchiarulo M, Cairo M, Facchetti R, Dell’Oro R, Grassi G, Mancia G. Relationship among morning blood pressure surge, 24-hour blood pressure variability, and cardiovascular outcomes in a white population. Hypertension. 2014;64(5):943-950.
37. Kario K. Orthostatic hypertension-a new haemodynamic cardiovascular risk factor. Nat Rev Nephrol. 2013;9:726-738.
38. Parati G, Vrijens B, Vincze G. Analysis and interpretation of 24-h blood pressure profi les: appropriate mathematical models may yield deeper understanding. Am J Hypertens. 2008;21:123-125.
39. Head GA, Chatzivlastou K, Lukoshkova EV, Jennings GL, Reid CM. A novel measure of the power of the morning blood pressure surge from ambulatory blood pressure recordings. Am J Hypertens. 2010;23(10):1074-1081.
40. Gosse P, Lasserre R, Minifie C, Lemetayer P, Clementy J. Blood pressure surge on rising. J Hypertens. 2004;22:1113-1118.
41. Kario K, Schwartz JE, Pickering TG. Ambulatory physical activity as a determinant of diurnal blood pressure variation. Hypertension. 1999;34:685-691.
42. Metoki H, Ohkubo T, Kikuya M, Asayama K, Obara T, Hashimoto J, Totsune K, Hoshi H, Satoh H, Imai Y. Prognostic signifi cance for stroke of a morning pressor surge and a nocturnal blood pressure decline: the Ohasama study. Hypertension. 2006;47(2):149-154.
43. Sheppard JP, Hodgkinson J, Riley R, Martin U, Bayliss S, McManus RJ. Prognostic signifi cance of the morning blood pressure surge in clinical practice: a systematic review. Am J Hypertens. 2015;28(1):30-41.
44. Verdecchia P, Angeli F, Mazzotta G, Garofoli M, Ramundo E, Gentile G, Ambrosio G, Reboldi G. Day-night dip and early-morning surge in blood pressure in hypertension:prognostic implications. Hypertension. 2012;60:34-42.
45. Israel S, Israel A, Ben-Dov IZ, Bursztyn M. The morning blood pressure surge and allcause mortality in patients referred for ambulatory blood pressure monitoring. Am J Hypertens. 2011;24:796-801.
46. Kuwajima I, Mitani K, Miyao M, Suzuki Y, Kuramoto K, Ozawa T. Cardiac implications of the morning surge in blood pressure in elderly hypertensive patients: relation to arising time. Am J Hypertens. 1995;8:29-33.
47. Marfella R, Gualdiero P, Siniscalchi M, Carusone C, Verza M, Marzano S, Esposito K, Giugliano D. Morning blood pressure peak, QT intervals, and sympathetic activity in hypertensive patients. Hypertension. 2003;41:237-243.
48. Kaneda R, Kario K, Hoshide S, Umeda Y, Hoshide Y, Shimada K. Morning blood pressure hyperreactivity is an independent predictor for hypertensive cardiac hypertrophy in a community-dwelling population. Am J Hypertens. 2005;18:1528-1533.
49. Yano Y, Hoshide S, Inokuchi T, Kanemaru Y, Shimada K, Kario K. Association between morning blood pressure surge and cardiovascular remodeling in treated elderly hypertensive subjects. Am J Hypertens. 2009;22:1177-1182.
50. Soylu A, Yazici M, Duzenli MA, Tokac M, Ozdemir K, Gok H. Relation between abnormalities in circadian blood pressure rhythm and target organ damage in normotensives. Circ J. 2009;73:899-904.
51. Zakopoulos NA, Tsivgoulis G, Barlas G, Papamichael C, Spengos K, Manios E, Ikonomidis I, Kotsis V, Spiliopoulou I, Vemmos K, Mavrikakis M, Moulopoulos SD. Time rate of blood pressure variation is associated with increased common carotid artery intimamedia thickness. Hypertension. 2005;45:505-512.
52. Marfella R, Siniscalchi M, Nappo F, Gualdiero P, Esposito K, Sasso FC, Cacciapuoti F, Di Filippo C, Rossi F, D’Amico M, Giugliano D. Regression of carotid atherosclerosis by control of morning blood pressure peak in newly diagnosed hypertensive patients. Am J Hypertens. 2005;18:308-318.
53. Marfella R, Siniscalchi M, Portoghese M, Di Filippo C, Ferraraccio F, Schiattarella C, Crescenzi B, Sangiuolo P, Ferraro G, Siciliano S, Cinone F, Mazzarella G, Martis S, Verza M, Coppola L, Rossi F, D’Amico M, Paolisso G. Morning blood pressure surge as a destabilizing factor of atherosclerotic plaque: role of ubiquitin-proteasome activity. Hypertension . 2007;49:784-791.
54. Shimizu M, Ishikawa J, Yano Y, Hoshide S, Shimada K, Kario K. The relationship between the morning blood pressure surge and low-grade infl ammation on silent cerebral infarct and clinical stroke events. Atherosclerosis. 2011;219:316-321.
55. Kario K. Treatment of early morning surges in blood pressure. In: Clinical Challenges in Hypertension Management (D Sicca, P Toth, eds). Atlas Medical Publishing, Oxford, UK, pp. 27-38, 2010.
56. Polónia J, Amado P, Barbosa L, Nazaré J, Silva JA, Bertoquini S, Martins L, Carmona J. Morning rise, morning surge and daytime variability of blood pressure and cardiovascular target organ damage. A cross-sectional study in 743 subjects. Rev Port Cardiol. 2005;24:65-78.
57. Kario K, Pickering TG, Hoshide S, Eguchi K, Ishikawa J, Morinari M, Hoshide Y, Shimada K. Morning blood pressure surge and hypertensive cerebrovascular disease: role of the alpha-adrenergic sympathetic nervous system. Am J Hypertens. 2004;17:668-675.
58. Kimura G. Kidney and circadian blood pressure rhythm. Hypertension. 2008;51:827-828.
59. Fukuda M, Mizuno M, Yamanaka T, Motokawa M, Shirasawa Y, Nishio T, Miyagi S, Yoshida A, Kimura G. Patients with renal dysfunction require a longer duration until blood pressure dips during the night. Hypertension. 2008;52:1155-1160.
60. Lurbe E, Redon J, Kesani A, Pascual JM, Tacons J, Alvarez V, Batlle D. Increase in nocturnal blood pressure and progression to microalbuminuria in type 1 diabetes. N Engl J Med. 2002;347:797-805.
61. Caramori ML, Pecis M, Azevedo MJ. Increase in nocturnal blood pressure and progression to microalbuminuria in diabetes. N Engl J Med. 2003;348:261-262.
62. Kawai T, Kamide K, Onishi M, Yamamoto-Hanasaki H, Baba Y, Hongyo K, Shimaoka I, Tatara Y, Takeya Y, Ohishi M, Rakugi H. Usefulness of the resistive index in renal Doppler ultrasonography as an indicator of vascular damage in patients with risks of atherosclerosis. Nephrol Dial Transplant. 2011;26(10):3256-3262.
63. Shimizu M, Ishikawa J, Eguchi K, Hoshide S, Shimada K, Kario K. Association of an abnormal blood glucose level and morning blood pressure surge in elderly subjects with hypertension. Am J Hypertens. 2009;22:611-616.
64. Ohira T, Tanigawa T, Tabata M, Imano H, Kitamura A, Kiyama M, Sato S, Okamura T, Cui R, Koike KA, Shimamoto T, Iso H. Effects of habitual alcohol intake on ambulatory blood pressure, heart rate, and its variability among Japanese men. Hypertension. 2009;53:13-19.
65. Kario K, Eguchi K, Hoshide S, Hoshide Y, Umeda Y, Mitsuhashi T, Shimada K. U-curve relationship between orthostatic blood pressure change and silent cerebrovascular disease in elderly hypertensives: orthostatic hypertension as a new cardiovascular risk factor. J Am Coll Cardiol. 2002;40:133-141.
66. Murakami S, Otsuka K, Kubo Y, Shinagawa M, Yamanaka T, Ohkawa S, Kitaura Y. Repeated ambulatory monitoring reveals a Monday morning surge in blood pressure in a community-dwelling population. Am J Hypertens. 2004;17:1179-1183.
67. Modesti PA, Morabito M, Bertolozzi I, Massetti L, Panci G, Lumachi C, Giglio A, Bilo G, Caldara G, Lonati L, Orlandini S, Mancia G, Gensini GF, Parati G. Weather related changes in 24-hour blood pressure profi le: effects of age and implications for hypertension management. Hypertension. 2006;47:155-161.
68. Murakami S, Otsuka K, Kono T, Soyama A, Umeda T, Yamamoto N, Morita H, Yamanaka G, Kitaura Y. Impact of outdoor temperature on prewaking morning surge and nocturnal decline in blood pressure in a Japanese population. Hypertens Res. 2011;34(1):70-73.
69. Kario K. Caution for winter morning sur1ge in blood pressure: a possible link with cardiovascular risk in the elderly. Hypertension. 2006;47:139-140.
70. Amin R, Somers VK, McConnell K, Willging P, Myer C, Sherman M, McPhail G, Morgenthal A, Fenchel M, Bean J, Kimball T, Daniels S. Activity-adjusted 24-hour ambulatory blood pressure and cardiac remodeling in children with sleep disordered breathing. Hypertension. 2008;51:84-91.
71. Kario K. Vascular damage in exaggerated morning surge in blood pressure. Hypertension. 2007;49(4):771-772.
72. Otto ME, Svatikova A, Barretto RB, Santos S, Hoffmann M, Khandheria B, Somers V. Early morning attenuation of endothelial function in healthy humans. Circulation. 2004;109(21):2507-2510.
73. Linsell CR, Lightman SL, Mullen PE, Brown MJ, Causon RC. Circadian rhythms of epinephrine and norepinephrine in man. J Clin Endocrinol Metab. 1985;60:1210-1215.
74. Kawasaki T, Cugini P, Uezono K, Sasaki H, Itoh K, Nishiura M, Shinkawa K. Circadian variations of total renin, active renin, plasma renin activity and plasma aldosterone in clinically healthy young subjects. Horm Metab Res. 1990;22:636-639.
75. Kario K, Yano Y, Matsuo T, Hoshide S, Eguchi K, Shimada K. Additional impact of morning haemostatic risk factors and morning blood pressure surge on stroke risk in older Japanese hypertensive patients. Eur Heart J. 2011;32(5):574-580.
76. Kario K, Yano Y, Matsuo T, Hoshide S, Asada Y, Shimada K. Morning blood pressure surge, morning platelet aggregation, and silent cerebral infarction in older Japanese hypertensive patients. J Hypertens. 2011;29(12):2433-2439.
77. Rizzoni D, Porteri E, Platto C, Rizzardi N, De Ciuceis C, Boari GE, Muiesan ML, Salvetti M, Zani F, Miclini M, Paiardi S, Castellano M, Rosei EA. Morning rise of blood pressure and subcutaneous small resistance artery structure. J Hypertens. 2007;25:1698-1703.
78. Folkow B. Physiological aspects of primary hypertension. Physiol Rev. 1982;62:347-504.
79. Schiffrin EL. Remodeling of resistance arteries in essential hypertension and effects of antihypertensive treatment. Am J Hypertens. 2004;17:1192-1200.
80. Panza JA, Epstein SE, Quyyumi AA. Circadian variation in vascular tone and its relation to alpha-sympathetic vasoconstrictor activity. N Engl J Med. 1991;325:986-990.
81. Brandenberger G, Follenius M, Goichot B, Saini J, Spiegel K, Ehrhart J, Simon C. Twenty-four-hour profi les of plasma renin activity in relation to the sleep-wake cycle. J Hypertens. 1994;12:277-283.
82. Naito Y, Tsujino T, Fujioka Y, Ohyanagi M, Iwasaki T. Augmented diurnal variations of the cardiac renin-angiotensin system in hypertensive rats. Hypertension. 2002;40:827-833.
83. Tissot AC, Maurer P, Nussberger J, Sabat R, Pfister T, Ignatenko S, Volk HD, Stocker H, Müller P, Jennings GT, Wagner F, Bachmann MF. Effect of immunisation against angiotensin II with CYT006-AngQb on ambulatory blood pressure: a double-blind, randomised, placebo-controlled phase IIa study. Lancet. 2008;371:821-827.
84. Tochikubo O, Kawano Y, Miyajima E, Toshihiro N, Ishii M. Circadian variation of hemodynamics and barorefl ex functions in patients with essential hypertension. Hypertens Res. 1997;20:157-166.
85. Sega R, Facchetti R, Bombelli M, Cesana G, Corrao G, Grassi G, Mancia G. Prognostic value of ambulatory and home blood pressures compared with offi ce blood pressure in the general population: follow-up results from the Pressioni Arteriose Monitorate e Loro Associazioni (PAMELA) study. Circulation. 2005;111:1777-1783.
86. Boggia J, Li Y, Thijs L, Hansen TW, Kikuya M, Bjorklund-Bodegård K, Richart T, Ohkubo T, Kuznetsova T, Torp-Pedersen C, Lind L, Ibsen H, Imai Y, Wang J, Sandoya E, O’Brien E, Staessen JA; International Database on Ambulatory blood pressure monitoring in relation to Cardiovascular Outcomes (IDACO) investigators. Prognostic accuracy of day versus night ambulatory blood pressure: a cohort study. Lancet. 2007;370:1219-1229.
87. Hoshide S, Kario K, Hoshide Y, Umeda Y, Hashimoto T, Kunii O, Ojima T, Shimada K. Associations between nondipping of nocturnal blood pressure decrease and cardiovascular target organ damage in strictly selected community-dwelling normotensives. Am J Hypertens. 2003;16:434-438.
88. Ohkubo T, Hozawa A, Yamaguchi J, Kikuya M, Ohmori K, Michimata M, Matsubara M, Hashimoto J, Hoshi H, Araki T, Tsuji I, Satoh H, Hisamichi S, Imai Y. Prognostic significance of the nocturnal decline in blood pressure in individuals with and without high 24-h blood pressure: the Ohasama study. J Hypertens. 2002;20:2183-2189.
89. O’Brien E, Sheridan J, O’Malley K. Dippers and non-dippers. Lancet. 1988;2(8607):397.
90. Shimada K, Kawamoto A, Matsubayashi K, Ozawa T. Silent cerebrovascular disease in the elderly. Correlation with ambulatory pressure. Hypertension. 1990;16(6):692-699.
91. Kario K, Schwartz JE, Pickering TG. Changes of nocturnal blood pressure dipping status in hypertensives by nighttime dosing of alpha-adrenergic blocker, doxazosin: results from the HALT study. Hypertension. 2000;35(3):787-794.
92. Kario K, Shimada K. Risers and extreme-dippers of nocturnal blood pressure in hypertension:Antihypertensive strategy for nocturnal blood pressure. Clin Exp Hypertens. 2004;26:177-189.
93. Eguchi K, Pickering TG, Schwartz JE, Hoshide S, Ishikawa J, Ishikawa S, Shimada K, Kario K. Short sleep duration as an independent predictor of cardiovascular events in Japanese patients with hypertension. Arch Intern Med. 2008;168:2225-2231.
94. Kabutoya T, Hoshide S, Ishikawa J, Eguchi K, Shimada K, Kario K. The effect of pulse rate and blood pressure dipping status on the risk of stroke and cardiovascular disease in Japanese hypertensive patients. Am J Hypertens. 2010;23:749-755.
95. Nagai M, Hoshide S, Ishikawa J, Shimada K, Kario K. Ambulatory blood pressure as an independent determinant of brain atrophy and cognitive function in elderly hypertension. J Hypertens. 2008;26:1636-1641.
96. Nagai M, Hoshide S, Ishikawa J, Shimada K, Kario K. Insular cortex atrophy as an independent determinant of disrupted diurnal rhythm of ambulatory blood pressure in elderly hypertension. Am J Hypertens. 2009;22:723-729.
97. Yano Y, Inokuchi T, Hoshide S, Kanemaru Y, Shimada K, Kario K. Association of poor physical function and cognitive dysfunction with high nocturnal blood pressure level in treated elderly hypertensive patients. Am J Hypertens. 2011;24:285-291.
98. Komori T, Eguchi K, Tomizawa H, Ishikawa J, Hoshide S, Shimada K, Kario K. Factors associated with incident ischemic stroke in hospitalized heart failure patients: a pilot study. Hypertens Res. 2008;31:289-294.
99. Yano Y, Hoshide S, Shimizu M, Eguchi K, Ishikawa J, Ishikawa S, Shimada K, Kario K. Association of home and ambulatory blood pressure changes with changes in cardiovascular biomarkers during antihypertensive treatment. Am J Hypertens. 2012;25:306-312.
100. Kario K, Schwartz JE, Davidson KW, Pickering TG. Gender differences in associations of diurnal blood pressure variation, awake physical activity and sleep quality with negative affect: The Work Site Blood Pressure Study. Hypertension. 2001;38:997-1002.
101. Kario K. Are melatonin and its receptor agonist specifi c antihypertensive modulators of resistant hypertension caused by disrupted circadian rhythm? J Am Soc Hypertens. 2011;5:354-358.
102. Eguchi K, Pickering TG, Hoshide S, Ishikawa J, Ishikawa S, Schwartz JE, Shimada K, Kario K. Ambulatory blood pressure is a better marker than clinic blood pressure in predicting cardiovascular events in patients with/without type 2 diabetes. Am J Hypertens . 2008;21(4):443-450.
103. Yano Y, Hayakawa M, Kuroki K, Ueno H, Yamagishi S, Takeuchi M, Eto T, Nagata N, Nakazato M, Shimada K, Kario K. Nighttime blood pressure, nighttime glucose values, and target-organ damages in treated type 2 diabetes patients. Atherosclerosis.2013;227(1):135-139.
104. Kamoi K, Miyakoshi M, Soda S, Kaneko S, Nakagawa O. Usefulness of home blood pressure measurement in the morning in type 2 diabetic patients. Diabetes Care. 2002;25(12):2218-2223.
105. Ishikawa J, Shimizu M, Hoshide S, Eguchi K, Pickering TG, Shimada K, Kario K. Cardiovascular risks of dipping status and chronic kidney disease in elderly Japanese hypertensive patients. J Clin Hypertens (Greenwich). 2008;10(10):787-794.
106. Watanabe N, Imai Y, Nagai K, Tsuji I, Satoh H, Sakuma M, Sakuma H, Kato J, Onodera-Kikuchi N, Yamada M, Abe F, Hisamichi S, Abe K. Nocturnal blood pressure and silent cerebrovascular lesions in elderly Japanese. Stroke. 1996;27(8):1319-1327.
107. Siennicki-Lantz A, Reinprecht F, Axelsson J, Elmståhl S. Cerebral perfusion in the elderly with nocturnal blood pressure fall. Eur J Neurol. 2007;14(7):715-720.
108. Jerrard-Dunne P, Mahmud A, Feely J. Circadian blood pressure variation: relationship between dipper status and measures of arterial stiffness. J Hypertens. 2007;25(6):1233-1239.
109. Viera AJ, Lin FC, Hinderliter AL, Shimbo D, Person SD, Pletcher MJ, Jacobs DR Jr. Nighttime blood pressure dipping in young adults and coronary artery calcium 10-15 years later: the coronary artery risk development in young adults study. Hypertension. 2012;59(6):1157-1163.
110. Kario K. Proposal of a new strategy for ambulatory blood pressure profi le-based management of resistant hypertension in the era of renal denervation. Hypertens Res. 2013;36:478-484.
111. Kario K. Systemic hemodynamic atherothrombotic syndrome: A blind spot in the current management of hypertension. J Clin Hypertens (Greenwich). 2015 in press.
112. Ito S, Nagasawa T, Abe M, Mori T. Strain vessel hypothesis: a viewpoint for linkage of albuminuria and cerebro-cardiovascular risk. Hypertens Res. 2009;32:115-121.
113. Briet M, Boutouyrie P, Laurent S, London GM. Arterial stiffness and pulse pressure in CKD and ESRD. Kidney Int. 2012;82(4):388-400.
114. Nakase T, Yoshioka S, Sasaki M, Suzuki A. Clinical evaluation of lacunar infarction and branch atheromatous disease. J Stroke Cerebrovasc Dis. 2013;22:406-412.
115. Kario K, Eguchi K, Nakagawa Y, Motai K, Shimada K. Relationship between extreme dippers and orthostatic hypertension in elderly hypertensive patients. Hypertension. 1998;31(1):77-82.
116. Nagai M, Hoshide S, Nishikawa M, Masahisa S, Kario K. Visit-to-visit blood pressure variability in the elderly: associations with cognitive impairment and carotid artery remodeling. Atherosclerosis. 2014;233(1):19-26.
117. Matsui Y, Eguchi K, Shibasaki S, Ishikawa J, Hoshide S, Shimada K, Kario K; Japan morning Surge-1 Study Group. Impact of arterial stiffness reduction on urinary albumin excretion during antihypertensive treatment: the Japan morning Surge-1 study. J Hypertens. 2010;28(8):1752-1760.
118. Toriumi S, Hoshide S, Nagai M, Kario K. Day-to-day blood pressure variability as a phenotype in a high-risk patient. Geriatr Gerontol Int. 2014;14(4):1005-1006.
119. Eguchi K, Murakami A, Horaguchi T, Kato M, Miyashita H, Kario K. Percutaneous transluminal angioplasty for peripheral artery disease confers cardiorenal protection. J Hum Hypertens. 2014;28(1):51-55.
120. Matsui Y, Ishikawa J, Eguchi K, Shibasaki S, Shimada K, Kario K. Maximum value of home blood pressure: a novel indicator of target organ damage in hypertension. Hypertension . 2011;57(6):1087-1093.
121. Kikuya M, Ohkubo T, Metoki H, Asayama K, Hara A, Obara T, Inoue R, Hoshi H, Hashimoto J, Totsune K, Satoh H, Imai Y. Day-by-day variability of blood pressure and heart rate at home as a novel predictor of prognosis: the Ohasama study. Hypertension. 2008;52(6):1045-1050.
122. Kario K. Orthostatic hypertension: a measure of blood pressure variation for predicting cardiovascular risk. Circ J. 2009;73:1002-1007.
123. Hoshide S, Matsui Y, Shibasaki S, Eguchi K, Ishikawa J, Ishikawa S, Kabutoya T, Schwartz JE, Pickering TG, Shimada K, Kario K; Japan Morning Surge-1 Study Group. Orthostatic hypertension detected by self-measured home blood pressure monitoring: a new cardiovascular risk factor for elderly hypertensives. Hypertens Res. 2008;31:1509-1516.
124. Hoshide S, Parati G, Matsui Y, Shibazaki S, Eguchi K, Kario K. Orthostatic hypertension:home blood pressure monitoring for detection and assessment of treatment with doxazosin. Hypertens Res. 2012;35(1):100-106.
125. Kario K, Matsuo T, Kobayashi H, Yamamoto K, Shimada K. Earthquake-induced potentiation of acute risk factors in hypertensive elderly patients: possible triggering of cardiovascular events after a major earthquake. J Am Coll Cardiol. 1997;29:926-933.
126. Kario K, McEwen BS, Pickering TG. Disasters and the heart: a review of the effects of earthquake-induced stress on cardiovascular disease. Hypertens Res. 2003;26:355-367.
127. Kario K. Disaster hypertension-its characteristics, mechanism, and management. Circ J. 2012;76(3):553-562.
128. Kario K, Matsuo T, Shimada K, Pickering TG. Factors associated with the occurrence and magnitude of earthquake-induced increases in blood pressure. Am J Med. 2001;111:379-384.
129. Kario K, Matsuo T, Ishida T, Shimada K. White coat hypertension and the Hanshin- Awaji earthquake. Lancet. 1995;345:1365.
130. Kario K, Nishizawa M, Hoshide S, Shimpo M, Ishibashi Y, Kunii O, Shibuya K. Development of a disaster cardiovascular prevention network. Lancet. 2011;378(9797):1125-1127.
131. Nishizawa M, Hoshide S, Shimpo M, Kario K. Disaster hypertension: experience from the great East Japan earthquake of 2011. Curr Hypertens Rep. 2012;14(5):375-381.
132. Kario K. Management of high casual blood pressure in a disaster. situation: the 1995 Hanshin-Awaji earthquake. Am J Hypertens. 1998;11:1138-1139.
133. Ishikawa J, Hoshide S, Eguchi K, Ishikawa S, Shimada K, Kario K. Nighttime home blood pressure and the risk of hypertensive target organ damage. Hypertension. 2012;60:921-928.
134. Kario K, Hoshide S, Haimoto H, Yamagiwa K, Uchiba K, Nagasaka S, Yano Y, Eguchi K, Matsui Y, Shimizu M, Ishikawa J, Ishikawa S, on behalf of the J-HOP study group. Sleep blood pressure self-measured at home as a novel determinant of organ damage: Japan Morning Surge Home Blood Pressure (J-HOP) Study. J Clin Hypertens (Greenwich). 2015 in press.
135. Ishikawa J, Shimizu M, Sugiyama Edison E, Yano Y, Hoshide S, Eguchi K, Kario K; J-TOP (Japan Morning Surge-Target Organ Protection) Study Investigators Group. Assessment of the reductions in night-time blood pressure and dipping induced by antihypertensive medication using a home blood pressure monitor. J Hypertens. 2014;32(1):82-89.
136. Shirasaki O, Kuwabara M, Saito M, Tagami K, Washiya S, Kario K. Development and clinical application of a new technique for detecting ‘sleep blood pressure surges’ in sleep apnea patients based on a variable desaturation threshold. Hypertens Res. 2011;34:922-928.
137. Kario K. Obstructive sleep apnea syndrome and hypertension: ambulatory blood pressure. Hypertens Res. 2009;32:428-432.
138. Kario K, Kuwabara M, Hoshide S, Nagai M, Shimpo M. Effects of nighttime single-dose administration of vasodilating vs sympatholytic antihypertensive agents on sleep blood pressure in hypertensive patients with sleep apnea syndrome. J Clin Hypertens (Greenwich). 2014;16(6):459-466.
139. Kario K. Obstructive sleep apnea syndrome and hypertension: mechanism of the linkage and 24-h blood pressure control. Hypertens Res. 2009;32:537-541.
140. Uzu T, Kimura G. Diuretics shift circadian rhythm of blood pressure from nondipper to dipper in essential hypertension. Circulation. 1999;100:1635-1638.
141. Eguchi K, Kario K, Hoshide Y, Hoshide S, Ishikawa J, Morinari M, Ishikawa S, Shimada K. Comparison of valsartan and amlodipine on ambulatory and morning blood pressure in hypertensive patients. Am J Hypertens. 2004;17(2):112-117.
142. Kario K, Odawara M, Kimura K, Node K. Nearly half of uncontrolled hypertensive patients could be controlled by high-dose titration of amlodipine in the clinical setting:the ACHIEVE Study. Curr Hypertens Rev. 2011;7:102-110.
143. Kario K, Shimada K. Differential effects of amlodipine on ambulatory blood pressure in elderly hypertensive patients with different nocturnal reductions in blood pressure. Am J Hypertens. 1997;10:261-268.
144. Wang JG, Kario K, Lau T, Wei YQ, Park CG, Kim CH, Huang J, Zhang W, Li Y, Yan P, Hu D; Asian Pacifi c Heart Association. Use of dihydropyridine calcium channel blockers in the management of hypertension in Eastern Asians: a scientifi c statement from the Asian Pacifi c Heart Association. Hypertens Res. 2011;34:423-430.
145. Kario K, Ando S, Kido H, Nariyama J, Takiuchi S, Yagi T, Shimizu T, Eguchi K, Ohno M, Kinoshita O, Yamada T. The effects of the L/N-type calcium channel blocker (cilnidipine) on sympathetic hyperactive morning hypertension: results from ACHIEVE-ONE. J Clin Hypertens (Greenwich). 2013;15(2):133-142.
146. Kario K, Nariyama J, Kido H, Ando S, Takiuchi S, Eguchi K, Niijima Y, Ando T, Noda M. Effect of a novel calcium channel blocker on abnormal nocturnal blood pressure in hypertensive patients. J Clin Hypertens (Greenwich). 2013;15(7):465-472.
147. Eguchi K, Tomizawa H, Ishikawa J, Hoshide S, Fukuda T, Numao T, Shimada K, Kario K. Effects of new calcium channel blocker, azelnidipine, and amlodipine on barorefl ex sensitivity and ambulatory blood pressure. J Cardiovasc Pharmacol. 2007;49(6):394-400.
148. Kario K, Uehara Y, Shirayama M, Takahashi M, Shiosakai K, Hiramatsu K, Komiya M, Shimada K. Study of sustained blood pressure-lowering effect of azelnidipine guided by self-measured morning and evening home blood pressure: subgroup analysis of the At-HOME study. Drugs R D. 2013;13(1):75-85.
149. Nonaka H, Emoto N, Ikeda K, Fukuya H, Rohman MS, Raharjo SB, Yagita K, Okamura H, Yokoyama M. Angiotensin II induces circadian gene expression of clock genes in cultured vascular smooth muscle cells. Circulation. 2001;104(15):1746-1748.
150. Kuroda T, Kario K, Hoshide S, Hashimoto T, Nomura Y, Saito Y, Mito H, Shimada K. Effects of bedtime vs. morning administration of the long-acting lipophilic angiotensinconverting enzyme inhibitor trandolapril on morning blood pressure in hypertensive patients. Hypertens Res. 2004;27(1):15-20.
151. White WB, Lacourciere Y, Davidai G. Effects of the angiotensin II receptor blockers telmisartan versus valsartan on the circadian variation of blood pressure: impact on the early morning period. Am J Hypertens. 2004;17:347-353.
152. Eguchi K, Kario K, Shimada K. Comparison of candesartan with lisinopril on ambulatory blood pressure and morning surge in patients with systemic hypertension. Am J Cardiol. 2003;92:621-624.
153. Kario K, Hoshide S, Shimizu M, Yano Y, Eguchi K, Ishikawa J, Ishikawa S, Shimada K. Effect of dosing time of angiotensin II receptor blockade titrated by self-measured blood pressure recordings on cardiorenal protection in hypertensives: the Japan Morning Surge-Target Organ Protection (J-TOP) study. J Hypertens. 2010;28(7):1574-1583.
154. Fukuda M, Yamanaka T, Mizuno M, Motokawa M, Shirasawa Y, Miyagi S, Nishio T, Yoshida A, Kimura G. Angiotensin II type 1 receptor blocker, olmesartan, restores nocturnal blood pressure decline by enhancing daytime natriuresis. J Hypertens. 2008;26:583-588.
155. Kario K, Saito I, Kushiro T, Teramukai S, Ishikawa Y, Hiramatsu K, Kobayashi F, Shimada K. Effect of the angiotensin II receptor antagonist olmesartan on morning home blood pressure in hypertension: HONEST study at 16 weeks. J Hum Hypertens. 2013;27:721-728.
156. Kario K, Saito I, Kushiro T, Teramukai S, Ishikawa Y, Kobayashi F, Shimada K. Effects of olmesartan-based treatment on masked, white-coat, poorly controlled, and well-controlled hypertension: HONEST study. J Clin Hypertens (Greenwich). 2014;16(6):442-450.
157. Kario K, Saito I, Kushiro T, Teramukai S, Mori Y, Hiramatsu K, Kobayashi F, Shimada K. Enhanced blood pressure-lowering effect of olmesartan in hypertensive patients with chronic kidney disease-associated sympathetic hyperactivity: HONEST study. J Clin Hypertens (Greenwich). 2013;15(8):555-561.
158. Rakugi H, Kario K, Enya K, Igeta M, Ikeda Y. Effect of azilsartan versus candesartan on nocturnal blood pressure variation in Japanese patients with essential hypertension. Blood Press. 2013;22(Suppl 1):22-28.
159. Rakugi H, Kario K, Enya K, Sugiura K, Ikeda Y. Effect of azilsartan versus candesartan on morning blood pressure surges in Japanese patients with essential hypertension. Blood Press Monit. 2014;19(3):164-169.
160. Pickering TG, Levenstein M, Walmsley P. Nighttime dosing of doxazosin has peak effect on morning ambulatory blood pressure. Results of the HALT Study. Hypertension and Lipid Trial Study Group. Am J Hypertens. 1994;7:844-847.
161. Kario K, Matsui Y, Shibasaki S, Eguchi K, Ishikawa J, Hoshide S, Ishikawa S, Kabutoya T, Schwartz JE, Pickering TG, Shimada K; Japan Morning Surge-1 (JMS-1) study group. An alpha-adrenergic blocker titrated by self-measured blood pressure record ings lowered blood pressure and microalbuminuria in patients with morning hypertension:the Japan Morning Surge-1 Study. J Hypertens. 2008;26:1257-1265.
162. Shibasaki S, Eguchi K, Matsui Y, Ishikawa J, Hoshide S, Ishikawa S, Kabutoya T, Pickering TG, Shimada K, Kario K; Japan Morning Surge-1 (JMS-1) Study Group. Adrenergic blockade improved insulin resistance in patients with morning hypertension:the Japan Morning Surge-1 Study. J Hypertens. 2009;27:1252-1257.
163. Matsui Y, Eguchi K, O’Rouke MF, Ishikawa J, Miyashita H, Shimada K, Kario K. Differential effects between a calcium channel blocker and a diuretic when used in combination with Angiotensin II receptor blocker on central aortic pressure in hypertensive patients. Hypertension. 2009;54:716-723.
164. Matsui Y, Eguchi K, Ishikawa J, Shimada K, Kario K. Urinary albumin excretion during angiotensin II receptor blockade: comparison of combination treatment with a diuretic or a calcium-channel blocker. Am J Hypertens. 2011;24:466-473.
165. Eguchi K, Hoshide S, Kabutoya T, Shimada K, Kario K. Is very low dose hydrochlorothiazide combined with candesartan effective in uncontrolled hypertensive patients? Blood Press Monit. 2010;15:308-311.
166. Matsui Y, O’Rourke MF, Hoshide S, Ishikawa J, Shimada K, Kario K. Combined effect of angiotensin II receptor blocker and either a calcium channel blocker or diuretic on day-by-day variability of home blood pressure: The Japan combined treatment with olmesartan and a calcium-channel blocker versus olmesartan and diuretics randomized effi cacy study. Hypertension. 2012;59:1132-1138.
167. Yano Y, Hoshide S, Tamaki N, Nagata M, Sasaki K, Kanemaru Y, Shimada K, Kario K. Effi cacy of eplerenone added to renin-angiotensin blockade in elderly hypertensive patients: the Jichi-Eplerenone Treatment (JET) study. J Renin Angiotensin Aldosterone Syst. 2011;12(3):340-347.
168. Kario K. Proposal of RAS-diuretic vs. RAS-calcium antagonist strategies in high-risk hypertension: insight from the 24-hour ambulatory blood pressure profi le and central pressure. J Am Soc Hypertens. 2010;4:215-218.
169. Daugherty SL, Powers JD, Magid DJ, Tavel HM, Masoudi FA, Margolis KL, O’Connor PJ, Selby JV, Ho PM. Incidence and prognosis of resistant hypertension in hypertensive patients. Circulation. 2012;125:1635-1642.
170. Pimenta E, Gaddam KK, Oparil S, Aban I, Husain S, Dell’Italia LJ, Calhoun DA. Effects of dietary sodium reduction on blood pressure in subjects with resistant hypertension:results from a randomized trial. Hypertension. 2009;54:475-481.
171. Uzu T, Ishikawa K, Fujii T, Nakamura S, Inenaga T, Kimura G. Sodium restriction shifts circadian rhythm of blood pressure from nondipper to dipper in essential hypertension. Circulation. 1997;96:1859-1862.
172. Nishizaka MK, Zaman MA, Calhoun DA. Effi cacy of low-dose spironolactone in subjects with resistant hypertension. Am J Hypertens. 2003;16:925-930.
173. Ruilope LM, Dukat A, Böhm M, Lacourcière Y, Gong J, Lefkowitz MP. Blood-pressure reduction with LCZ696, a novel dual-acting inhibitor of the angiotensin II receptor and neprilysin: a randomised, double-blind, placebo-controlled, active comparator study. Lancet. 2010;375:1255-1266.
174. Kario K, Sun N, Chiang FT, Supasyndh O, Baek SH, Inubushi-Molessa A, Zhang Y, Gotou H, Lefkowitz M, Zhang J. Effi cacy and safety of LCZ696, a fi rst-in-class angiotensin receptor neprilysin inhibitor, in Asian patients with hypertension: a randomized, double-blind, placebo-controlled study. Hypertension. 2014;63(4):698-705.
175. Solomon SD, Zile M, Pieske B, Voors A, Shah A, Kraigher-Krainer E, Shi V, Bransford T, Takeuchi M, Gong J, Lefkowitz M, Packer M, McMurray JJ; Prospective comparison of ARNI with ARB on Management Of heart failure with preserved ejection fraction (PARAMOUNT) Investigators. The angiotensin receptor neprilysin inhibitor LCZ696 in heart failure with preserved ejection fraction: a phase 2 double-blind randomised controlled trial. Lancet. 2012;380:1387-1395.
176. McMurray JJ, Packer M, Desai AS, Gong J, Lefkowitz MP, Rizkala AR, Rouleau JL, Shi VC, Solomon SD, Swedberg K, Zile MR; PARADIGM-HF Investigators and Committees. Angiotensin-neprilysin inhibition versus enalapril in heart failure. N Engl J Med. 2014;371(11):993-1004.
177. Krum H, Schlaich M, Whitbourn R, Sobotka PA, Sadowski J, Bartus K, Kapelak B, Walton A, Sievert H, Thambar S, Abraham WT, Esler M. Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study. Lancet. 2009;373:1275-1281.
178. Esler MD, Krum H, Sobotka PA, Schlaich MP, Schmieder RE, Böhm M; Symplicity HTN-2 Investigators. Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial. Lancet. 2010;376:1903-1909.
179. Bhatt DL, Kandzari DE, O’Neill WW, D’Agostino R, Flack JM, Katzen BT, Leon MB, Liu M, Mauri L, Negoita M, Cohen SA, Oparil S, Rocha-Singh K, Townsend RR, Bakris GL; SYMPLICITY HTN-3 Investigators. A controlled trial of renal denervation for resistant hypertension. N Engl J Med. 2014;370(15):1393-1401.
180. Mahfoud F, Schlaich M, Kindermann I, Ukena C, Cremers B, Brandt MC, Hoppe UC, Vonend O, Rump LC, Sobotka PA, Krum H, Esler M, Böhm M. Effect of renal sympathetic denervation on glucose metabolism in patients with resistant hypertension: a pilot study. Circulation. 2011;123:1940-1946.
181. Mahfoud F, Cremers B, Janker J, Link B, Vonend O, Ukena C, Linz D, Schmieder R, Rump LC, Kindermann I, Sobotka PA, Krum H, Scheller B, Schlaich M, Laufs U, Böhm M. Renal hemodynamics and renal function after catheter-based renal sympathetic denervation in patients with resistant hypertension. Hypertension. 2012;60:419-424.
182. Brandt MC, Mahfoud F, Reda S, Schirmer SH, Erdmann E, Böhm M, Hoppe UC. Renal sympathetic denervation reduces left ventricular hypertrophy and improves cardiac function in patients with resistant hypertension. J Am Coll Cardiol. 2012;59:901-909.